ProQR Announces CTA Submission For Phase 1 Study Of AX-0810 Targeting NTCP

RefinitivMenos de 1 minuto de leitura

ProQR Therapeutics NV PRQR:

PROQR ANNOUNCES CTA SUBMISSION FOR PHASE 1 STUDY OF AX-0810 TARGETING NTCP

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Entrar ou criar uma conta gratuita para ler essa notícia